Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more
than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an …

BACKGROUND Traditionally, pregnancy was considered to have a positive effect on
endometriosis and its painful symptoms due not only to blockage of ovulation preventing …

The validation of prognostic biomarkers in large independent patient cohorts is a major
bottleneck in ovarian cancer research. We implemented an online tool to assess the …

CA 125 also known as mucin 16 or MUC16 is a large membrane glycoprotein belonging to
the wide mucin family, encoded by the homonymous MUC16 gene. Following its discovery …

Background: Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human
epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as …

OBJECTIVE: It is often difficult to distinguish a benign pelvic mass from a malignancy and
tools to help referring physician are needed. The purpose of this study was to validate the …

According to the latest statistics, cancer is expected to account for nearly 1800000 new
cases and about 607000 deaths in the US in 2019. Approximately 40% of people with …

Ovarian cancer is a deadly disease for which there is no effective means of early detection.
Ovarian carcinomas comprise a diverse group of neoplasms, exhibiting a wide range of …

Ovarian cancer is the eighth-most common cause of death among women worldwide. In the
absence of distinctive symptoms in the early stages, the majority of women are diagnosed in …

OBJECTIVE: Diagnostic factors are needed to improve the currently used serum CA125 and
risk of malignancy index (RMI) in differentiating ovarian cancer (OC) from other pelvic …